The store will not work correctly when cookies are disabled.
4-(Pyridin-4-yl)-N-(3-(trifluoromethoxy)benzyl)benzamide
ID: ALA4475535
PubChem CID: 155538076
Max Phase: Preclinical
Molecular Formula: C20H15F3N2O2
Molecular Weight: 372.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1cccc(OC(F)(F)F)c1)c1ccc(-c2ccncc2)cc1
Standard InChI: InChI=1S/C20H15F3N2O2/c21-20(22,23)27-18-3-1-2-14(12-18)13-25-19(26)17-6-4-15(5-7-17)16-8-10-24-11-9-16/h1-12H,13H2,(H,25,26)
Standard InChI Key: BGSKZKNLGRQZGZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
23.0657 -10.2190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0645 -11.0426 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.7767 -11.4516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4905 -11.0422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4876 -10.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7749 -9.8060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1949 -9.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9044 -10.2130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6143 -9.7983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6116 -8.9762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8933 -8.5704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1905 -8.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3214 -8.5640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0353 -8.9689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3172 -7.7427 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.7450 -8.5567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4589 -8.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4616 -9.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1746 -10.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8812 -9.7753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8744 -8.9497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1649 -8.5485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5827 -8.5350 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2980 -8.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0063 -8.5228 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.3051 -9.7588 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.0054 -9.3482 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
23 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 372.35 | Molecular Weight (Monoisotopic): 372.1086 | AlogP: 4.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 51.22 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.95 | CX LogP: 4.63 | CX LogD: 4.63 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.71 | Np Likeness Score: -1.29 |
References
1. Hobson AD, Judge RA, Aguirre AL, Brown BS, Cui Y, Ding P, Dominguez E, DiGiammarino E, Egan DA, Freiberg GM, Gopalakrishnan SM, Harris CM, Honore MP, Kage KL, Kapecki NJ, Ling C, Ma J, Mack H, Mamo M, Maurus S, McRae B, Moore NS, Mueller BK, Mueller R, Namovic MT, Patel K, Pratt SD, Putman CB, Queeney KL, Sarris KK, Schaffter LM, Stoll V, Vasudevan A, Wang L, Wang L, Wirthl W, Yach K.. (2018) Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design., 61 (24): [PMID:30384606] [10.1021/acs.jmedchem.8b01098] |